Cargando…

Nanoformulations targeting immune cells for cancer therapy: mRNA therapeutics

The approved worldwide use of two messenger RNA (mRNA) vaccines (BNT162b2 and mRNA-1273) in late 2020 has proven the remarkable success of mRNA therapeutics together with lipid nanoformulation technology in protecting people against coronaviruses during COVID-19 pandemic. This unprecedented and exci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Wei, Cao, Jianwei, Cheng, Hui, Chen, Liang, Yu, Meihua, Chen, Yu, Cui, Xingang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	KeAi Publishing 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712057/ https://www.ncbi.nlm.nih.gov/pubmed/36471724 http://dx.doi.org/10.1016/j.bioactmat.2022.11.014

Ejemplares similares

Optimization of Lipid Nanoformulations for Effective mRNA Delivery
por: Chen, Huiling, et al.
Publicado: (2022)

Targeted Cancer Immunotherapy: Nanoformulation Engineering and Clinical Translation
por: Yu, Meihua, et al.
Publicado: (2022)

Multi-Targeting Intranasal Nanoformulation as a Therapeutic for Alzheimer’s Disease
por: Fihurka, Oksana, et al.
Publicado: (2023)

Investigating Polyphenol Nanoformulations for Therapeutic Targets against Diabetes Mellitus
por: Islam, Fahadul, et al.
Publicado: (2022)

Liver Cell Type-Specific Targeting by Nanoformulations for Therapeutic Applications
por: Kaps, Leonard, et al.
Publicado: (2023)

mRNA as a Therapeutics: Understanding mRNA Vaccines
por: Oğuz, Ferdi, et al.
Publicado: (2022)

The Delivery of mRNA Vaccines for Therapeutics
por: Nitika,, et al.
Publicado: (2022)

Optimization of mRNA untranslated regions for improved expression of therapeutic mRNA
por: Asrani, Kirtika H., et al.
Publicado: (2018)

Nanomaterials for mRNA‐based therapeutics: Challenges and opportunities
por: Li, De‐feng, et al.
Publicado: (2023)

Identification of tumor antigens and immune subtypes in head and neck squamous cell carcinoma for mRNA vaccine development
por: Chen, Yan, et al.
Publicado: (2022)

Macrophage‐Derived Extracellular Vesicles‐Coated Palladium Nanoformulations Modulate Inflammatory and Immune Homeostasis for Targeting Therapy of Ulcerative Colitis
por: Cheng, Jiahui, et al.
Publicado: (2023)

mRNA-Based Therapeutics in Cancer Treatment
por: Sun, Han, et al.
Publicado: (2023)

Recent Advances in Inhaled Nanoformulations of Vaccines and Therapeutics Targeting Respiratory Viral Infections
por: Loo, Ching-Yee, et al.
Publicado: (2023)

Therapeutic Prospects of mRNA-Based Gene Therapy for Glioblastoma
por: Tang, Xiangjun, et al.
Publicado: (2019)

Natural Products-Based Nanoformulations: A New Approach Targeting CSCs to Cancer Therapy
por: Liao, Wenhao, et al.
Publicado: (2022)

The Dual Role of the Innate Immune System in the Effectiveness of mRNA Therapeutics
por: Muslimov, Albert, et al.
Publicado: (2023)

Effect of the nanoformulation of siRNA-lipid assemblies on their cellular uptake and immune stimulation
por: Kubota, Kohei, et al.
Publicado: (2017)

mRNA therapeutics in cancer immunotherapy
por: Beck, Jan D., et al.
Publicado: (2021)

Resveratrol-Based Nanoformulations as an Emerging Therapeutic Strategy for Cancer
por: Sharifi-Rad, Javad, et al.
Publicado: (2021)

Immunomodulatory and anti-inflammatory therapeutic potential of gingerols and their nanoformulations
por: Yücel, Çiğdem, et al.
Publicado: (2022)

Synthetic mRNA-based gene therapy for glioblastoma: TRAIL-mRNA synergistically enhances PTEN-mRNA-based therapy
por: Tang, Xiangjun, et al.
Publicado: (2022)

MicroRNA, mRNA, and Proteomics Biomarkers and Therapeutic Targets for Improving Lung Cancer Treatment Outcomes
por: Ye, Qing, et al.
Publicado: (2023)

Specificity of mRNA Folding and Its Association with Evolutionarily Adaptive mRNA Secondary Structures
por: Yu, Gongwang, et al.
Publicado: (2021)

mRNA nanodelivery systems: targeting strategies and administration routes
por: Yuan, Mujie, et al.
Publicado: (2023)

Reprogrammed mRNA translation drives resistance to therapeutic targeting of ribosome biogenesis
por: Kusnadi, Eric P, et al.
Publicado: (2020)

Targeting pre-mRNA splicing in cancers: roles, inhibitors, and therapeutic opportunities
por: Araki, Shinsuke, et al.
Publicado: (2023)

Identification of Immune-Related Prognostic mRNA and lncRNA in Patients with Hepatocellular Carcinoma
por: Chen, Dan, et al.
Publicado: (2022)

A multifunctional DNA nano-scorpion for highly efficient targeted delivery of mRNA therapeutics
por: Li, Dandan, et al.
Publicado: (2018)

Therapeutic potential of curcumin and its nanoformulations for treating oral cancer
por: Mukherjee, Diptasree, et al.
Publicado: (2023)

Application of mRNA Technology in Cancer Therapeutics
por: Eralp, Yesim
Publicado: (2022)

Modified mRNA Therapeutics for Heart Diseases
por: Magadum, Ajit
Publicado: (2022)

mRNA therapeutics: New vaccination and beyond
por: Wei, Huan-Huan, et al.
Publicado: (2023)

Discrepant mRNA and Protein Expression in Immune Cells
por: Li, Jiawei, et al.
Publicado: (2020)

Immunity of the Saccharomyces cerevisiae SSY5 mRNA to nonsense-mediated mRNA decay
por: Obenoskey, Jesseeca, et al.
Publicado: (2014)

LncRNA and mRNA expression associated with myasthenia gravis in patients with thymoma
por: Ke, Ji, et al.
Publicado: (2021)

Yeast targets for mRNA methylation
por: Bodi, Zsuzsanna, et al.
Publicado: (2010)

Target selectivity in mRNA silencing
por: Aronin, N
Publicado: (2006)

Identification of tumor antigens and immune subtypes of hepatocellular carcinoma for mRNA vaccine development
por: Lu, Tai-Liang, et al.
Publicado: (2023)

Potential Immune Biomarker Candidates and Immune Subtypes of Lung Adenocarcinoma for Developing mRNA Vaccines
por: Wang, Yang, et al.
Publicado: (2021)

Integrated Analysis of Immune-Related circRNA-miRNA-mRNA Regulatory Network in Ischemic Stroke
por: Cao, Si, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rnha56s0ph5tlss56gnjlvai76